Platelet endothelial cell adhesion molecule-1, stage-specific embryonic Antigen-1, and Flk-1 mark distinct populations of mouse embryonic stem cells during differentiation toward hematopoietic/endothelial cells

Stem Cells and Development

Volumn 19, Issue 12, 2010, Pages 1937-1948

  Yue, Wei ^a,b   Pi, Qing Meng ^a   Zhang, Wen Jie ^a   Zhou, Guang Dong ^a   Cui, Lei ^a   Liu, Wei ^a   Cao, Yilin ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; STAGE SPECIFIC EMBRYO ANTIGEN 1; VASCULOTROPIN RECEPTOR 2;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL SELECTION; ECTODERM; EMBRYO; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; HEMATOPOIETIC STEM CELL; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTIGENS, CD15; ANTIGENS, CD31; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL LINE; CELLS, CULTURED; EMBRYONIC STEM CELLS; ENDOTHELIAL CELLS; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HEMATOPOIESIS; MICE; POLYMERASE CHAIN REACTION; STAGE-SPECIFIC EMBRYONIC ANTIGENS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 78649705576     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2010.0096     Document Type: Article

References (40)

1. Smith AG. (1992). Mouse embryo stem cells: their identification, propagation and manipulation. Semin Cell Biol 3:385-399.
2. Gutierrez-Ramos JC and R Palacios. (1992). In vitro differentiation of embryonic stem cells into lymphocyte precursors able to generate T and B lymphocytes in vivo. Proc Natl Acad Sci USA 89:9171-9175.
3. Chung YS, WJ Zhang, E Arentson, PD Kingsley, J Palis and K Choi. (2002). Lineage analysis of the hemangioblast as defined by FLK1 and SCL expression. Development 129:5511-5520.
4. Choi K, M Kennedy, A Kazarov, JC Papadimitriou and G Keller. (1998). A common precursor for hematopoietic and endothelial cells. Development 125:725-732.
5. Carrithers M, S Tandon, S Canosa, M Michaud, D Graesser and JA Madri. (2005). Enhanced susceptibility to endotoxic shock and impaired STAT3 signaling in CD31-deficient mice. Am J Pathol 166:185-196.
6. Keller GM. (1995). In vitro differentiation of embryonic stem cells. Curr Opin Cell Biol 7:862-869.
7. Kabrun N, HJ Buhring, K Choi, A Ullrich, W Risau and G Keller. (1997). Flk-1 expression defines a population of early embryonic hematopoietic precursors. Development 124:2039-2048.
8. Wiles MV and G Keller. (1991). Multiple hematopoietic lineages develop from embryonic stem (ES) cells in culture. Development 111:259-267.
9. Keller G, M Kennedy, T Papayannopoulou and MV Wiles. (1993). Hematopoietic commitment during embryonic stem cell differentiation in culture. Mol Cell Biol 13:473-486.
10. Ema M, P Faloon, WJ Zhang, M Hirashima, T Reid, WL Stanford, S Orkin, K Choi and J Rossant. (2003). Combinatorial effects of Flk1 and Tal1 on vascular and hematopoietic development in the mouse. Genes Dev 17:380-393.
11. Vittet D, MH Prandini, R Berthier, A Schweitzer, H Martin-Sisteron, G Uzan and E Dejana. (1996). Embryonic stem cells differentiate in vitro to endothelial cells through successive maturation steps. Blood 88:3424-3431.
12. Shalaby F, J Rossant, TP Yamaguchi, M Gertsenstein, XF Wu, ML Breitman and AC Schuh. (1995). Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376:62-66.
13. Nishikawa SI, S Nishikawa, M Hirashima, N Matsuyoshi and H Kodama. (1998). Progressive lineage analysis by cell sorting and culture identifies FLK1\+VE-cadherin\+ cells at a diverging point of endothelial and hemopoietic lineages. Development 125:1747-1757.
14. Yamaguchi TP, DJ Dumont, RA Conlon, ML Breitman and J Rossant. (1993). flk-1, an flt-related receptor tyrosine kinase is an early marker for endothelial cell precursors. Development 118:489-498.
15. Fehling HJ, G Lacaud, A Kubo, M Kennedy, S Robertson, G Keller and V Kouskoff. (2003). Tracking mesoderm induction and its specification to the hemangioblast during embryonic stem cell differentiation. Development 130:4217-4227.
16. Robertson SM, M Kennedy, JM Shannon and G Keller. (2000). A transitional stage in the commitment of mesoderm to hematopoiesis requiring the transcription factor SCL=tal-1. Development 127:2447-2459.
17. Kim SJ, JS Kim, J Papadopoulos, S Wook Kim, M Maya, F Zhang, J He, D Fan, R Langley and IJ Fidler. (2009). Circulating monocytes expressing CD31:implications for acute and chronic angiogenesis. Am J Pathol 174:1972-1980.
18. Newman PJ and DK Newman. (2003). Signal transduction pathways mediated by PECAM-1: new roles for an old molecule in platelet and vascular cell biology. Arterioscler Thromb Vasc Biol 23:953-964.
19. Calabrese G, Fernandez de Recondo M, Recondo E, Wainstok de Calmanovici R. (2005). Platelet endothelial cell adhesion molecule-1 expression during mouse postimplantation development. Cell Mol Biol 44:537-541.
20. Robson P, P Stein, B Zhou, RM Schultz and HS Baldwin. (2001). Inner cell mass-specific expression of a cell adhesion molecule (PECAM-1=CD31) in the mouse blastocyst. Dev Biol 234:317-329.
21. Furusawa T, K Ohkoshi, C Honda, S Takahashi and T To-kunaga. (2004). Embryonic stem cells expressing both platelet endothelial cell adhesion molecule-1 and stage-specific embryonic antigen-1 differentiate predominantly into epiblast cells in a chimeric embryo. Biol Reprod 70:1452-1457.
22. Li ZJ, ZZ Wang, YZ Zheng, B Xu, RC Yang, DT Scadden and ZC Han. (2005). Kinetic expression of platelet endothelial cell adhesion molecule-1 (PECAM-1=CD31) during embryonic stem cell differentiation. J Cell Biochem 95:559-570. (Pubitemid 41420185)
23. Cui L, K Johkura, F Yue, N Ogiwara, Y Okouchi, K Asa-numa and K Sasaki. (2004). Spatial distribution and initial changes of SSEA-1 and other cell adhesion-related molecules on mouse embryonic stem cells before and during differentiation. J Histochem Cytochem 52:1447-1457.
24. Fox N, I Damjanov, A Martinez-Hernandez, BB Knowles and D Solter. (1981). Immunohistochemical localization of the early embryonic antigen (SSEA-1) in postimplantation mouse embryos and fetal and adult tissues. Dev Biol 83:391-398.
25. Kobayashi M, K Inoue, E Warabi, T Minami and T Kodama. (2005). A simple method of isolating mouse aortic endo-thelial cells. J Atheroscler Thromb 12:138-142.
26. Feraud O, Y Cao and D Vittet. (2001). Embryonic stem cell-derived embryoid bodies development in collagen gels recapitulates sprouting angiogenesis. Lab Invest 81:1669-1681.
27. Zhang WJ, C Park, E Arentson and K Choi. (2005). Modulation of hematopoietic and endothelial cell differentiation from mouse embryonic stem cells by different culture conditions. Blood 105:111-114.
28. Park C, I Afrikanova, YS Chung, WJ Zhang, E Arentson, G Fong Gh, A Rosendahl and K Choi. (2004). A hierarchical order of factors in the generation of FLK1-and SCL-expressing hematopoietic and endothelial progenitors from embryonic stem cells. Development 131:2749-2762.
29. Drake CJ and PA Fleming. (2000). Vasculogenesis in the day 6.5 to 9.5 mouse embryo. Blood 95:1671-1679.
30. Brons IG, LE Smithers, MW Trotter, P Rugg-Gunn, B Sun, SM Chuva de Sousa Lopes, SK Howlett, A Clarkson, L Ahrlund-Richter and RA Pedersen. (2007). Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature 448:191-195.
31. Hayashi K, SM Lopes, F Tang and MA Surani. (2008). Dynamic equilibrium and heterogeneity of mouse pluripotent stem cells with distinct functional and epigenetic states. Cell Stem Cell 3:, 391-401.
32. Guo G, J Yang, J Nichols, JS Hall, I Eyres, W Mansfield and A Smith. (2009). Klf4 reverts developmentally programmed restriction of ground state pluripotency. Development 136:1063-10.
33. Bao S, F Tang, X Li, K Hayashi, A Gillich, K Lao and MA Surani. (2009). Epigenetic reversion of post-implantation epiblast to pluripotent embryonic stem cells. Nature 461:1292-1295.
34. Hayashi K, Surani MA. (2009). Self-renewing epiblast stem cells exhibit continual delineation of germ cells with epige-netic reprogramming in vitro. Development 136:3549-3556.
35. Toyooka Y, D Shimosato, K Murakami, K Takahashi and H Niwa. (2008). Identification and characterization of sub-populations in undifferentiated ES cell culture. Development 135:909-918.
36. Watt SM, SE Gschmeissner and PA Bates. (1995). PECAM-1: its expression and function as a cell adhesion molecule on hemopoietic and endothelial cells. Leuk Lymphoma 17: 229-244.
37. Redick SD and VL Bautch. (1999). Developmental platelet endothelial cell adhesion molecule expression suggests multiple roles for a vascular adhesion molecule. Am J Pathol 154:1137-1347.
38. Carrithers M, S Tandon, S Canosa, M Michaud, D Graesser and JA Madri. (2005). Enhanced susceptibility to en-dotoxicshock and impaired STAT3 signaling in CD31-deficient mice. Am J Pathol 166:185-196.
39. Oka M, K Tagoku, TL Russell, Y Nakano, T Hamazaki, EM Meyer, T Yokota and N Terada, (2002). CD9 is associated with leukemia inhibitory factor-mediated maintenance of embryonic stem cells. Mol Biol Cell 13:1274-1281.
40. Duncan GS, DP Andrew, H Takimoto, SA Kaufman, H Yoshida, J Spellberg, J Luis de la Pompa, A Elia, A Wa-keham and B Karan-Tami. (1999). Genetic evidence for functional redundancy of Platelet=Endothelial cell adhesion molecule-1 (PECAM-1): CD31-deficient mice reveal PE-CAM-1-dependent and PECAM-1 independent functions. J Immunol 162:3022-3030.